These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9922988)

  • 21. Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Río J
    Brain Res; 1996 Mar; 712(2):274-80. PubMed ID: 8814902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
    Witkin JM; Nelson DL
    Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation.
    Gil-Bea FJ; Domínguez J; García-Alloza M; Marcos B; Lasheras B; Ramírez MJ
    Neuropharmacology; 2004 Aug; 47(2):225-32. PubMed ID: 15223301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice.
    Vohora D; Pal SN; Pillai KK
    Life Sci; 2000 Apr; 66(22):PL297-301. PubMed ID: 10834305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine H3 receptor antagonists: from target identification to drug leads.
    Bonaventure P; Letavic M; Dugovic C; Wilson S; Aluisio L; Pudiak C; Lord B; Mazur C; Kamme F; Nishino S; Carruthers N; Lovenberg T
    Biochem Pharmacol; 2007 Apr; 73(8):1084-96. PubMed ID: 17129577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of iodoproxyfan, a potent and selective histamine H3 receptor antagonist, on alpha 2 and 5-HT3 receptors.
    Schlicker E; Pertz H; Bitschnau H; Purand K; Kathmann M; Elz S; Schunack W
    Inflamm Res; 1995 Jul; 44(7):296-300. PubMed ID: 8564527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice.
    Onodera K; Miyazaki S; Imaizumi M; Stark H; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):508-13. PubMed ID: 9650802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.
    Galici R; Boggs JD; Aluisio L; Fraser IC; Bonaventure P; Lord B; Lovenberg TW
    Neuropharmacology; 2009 Jun; 56(8):1131-7. PubMed ID: 19345233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of 5-HT3 receptor antagonism on working memory failure due to deficiency of hippocampal cholinergic and glutamatergic transmission in rats.
    Ohno M; Watanabe S
    Brain Res; 1997 Jul; 762(1-2):211-5. PubMed ID: 9262175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
    Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
    Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models.
    Medhurst AD; Atkins AR; Beresford IJ; Brackenborough K; Briggs MA; Calver AR; Cilia J; Cluderay JE; Crook B; Davis JB; Davis RK; Davis RP; Dawson LA; Foley AG; Gartlon J; Gonzalez MI; Heslop T; Hirst WD; Jennings C; Jones DN; Lacroix LP; Martyn A; Ociepka S; Ray A; Regan CM; Roberts JC; Schogger J; Southam E; Stean TO; Trail BK; Upton N; Wadsworth G; Wald JA; White T; Witherington J; Woolley ML; Worby A; Wilson DM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1032-45. PubMed ID: 17327487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
    Ellenbroek BA; Ghiabi B
    Curr Pharm Des; 2015; 21(26):3760-70. PubMed ID: 26044979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
    Stark H; Ligneau X; Sadek B; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2379-82. PubMed ID: 11055360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice.
    Miyazaki S; Onodera K; Imaizumi M; Timmerman H
    Life Sci; 1997; 61(4):355-61. PubMed ID: 9244361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving rat.
    Bacciottini L; Passani MB; Giovannelli L; Cangioli I; Mannaioni PF; Schunack W; Blandina P
    Eur J Neurosci; 2002 May; 15(10):1669-80. PubMed ID: 12059975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in memory performance in the object recognition test. Possible role of histamine receptors.
    Ghi P; Orsetti M; Gamalero SR; Ferretti C
    Pharmacol Biochem Behav; 1999 Dec; 64(4):761-6. PubMed ID: 10593199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H3 autoreceptors and muscarinic acetylcholine receptors modulate histamine release in the anterior hypothalamus of freely moving rats.
    Prast H; Prast M; Philippu A
    Agents Actions; 1994 Jun; 41 Spec No():C64-5. PubMed ID: 7526662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of the effects of histamine, thioperamide and EEDQ on H3 receptors in the mouse brain.
    Detzner M; Kathmann M; Schlicker E
    Agents Actions; 1994 Jun; 41 Spec No():C66-7. PubMed ID: 7526663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.